Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Farnesyl and geranylgeranyl transferase inhibitors: an anti-inflammatory effect. Comment to "Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells" Haematologica. 2013;98(1):31-40.

Literature DB >> 23543155

Farnesyl and geranylgeranyl transferase inhibitors: an anti-inflammatory effect. Comment to "Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells" Haematologica. 2013;98(1):31-40.

Giulio Kleiner, Annalisa Marcuzzi, Giuseppina Campisciano, Sergio Crovella.

Abstract

Entities: Gene

Mesh：

Year: 2013 PMID： 23543155 PMCID： PMC3660002 DOI： 10.3324/haematol.2012.082040

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

Keyword Cloud
References

× No keyword cloud information.

10 in total

1. Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia.

Authors: Judith E Karp; Tatiana I Vener; Mitch Raponi; Ellen K Ritchie; B Douglas Smith; Steven D Gore; Lawrence E Morris; Eric J Feldman; Jacqueline M Greer; Sami Malek; Hetty E Carraway; Valerie Ironside; Steven Galkin; Mark J Levis; Michael A McDevitt; Gail R Roboz; Christopher D Gocke; Carlo Derecho; John Palma; Yixin Wang; Scott H Kaufmann; John J Wright; Elizabeth Garret-Mayer
Journal: Blood Date: 2011-10-14 Impact factor: 22.113

2. Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells.

Authors: Anne-Kathrin Hechinger; Kristina Maas; Christoph Dürr; Franziska Leonhardt; Gabriele Prinz; Reinhard Marks; Ulrike Gerlach; Maike Hofmann; Paul Fisch; Jürgen Finke; Hanspeter Pircher; Robert Zeiser
Journal: Haematologica Date: 2012-07-16 Impact factor: 9.941

3. Manumycin A, inhibitor of ras farnesyltransferase, inhibits proliferation and migration of rat vascular smooth muscle cells.

Authors: H Kouchi; K Nakamura; K Fushimi; M Sakaguchi; M Miyazaki; T Ohe; M Namba
Journal: Biochem Biophys Res Commun Date: 1999-11-02 Impact factor: 3.575

4. Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome.

Authors: Joost Frenkel; Ger T Rijkers; Saskia H L Mandey; Sandra W M Buurman; Sander M Houten; Ronald J A Wanders; Hans R Waterham; Wietse Kuis
Journal: Arthritis Rheum Date: 2002-10

5. Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches.

Authors: Luigina De Leo; Annalisa Marcuzzi; Giuliana Decorti; Alberto Tommasini; Sergio Crovella; Alessandra Pontillo
Journal: Pharmacol Res Date: 2010-03-03 Impact factor: 7.658

6. Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial.

Authors: J E Karp; J E Lancet; S H Kaufmann; D W End; J J Wright; K Bol; I Horak; M L Tidwell; J Liesveld; T J Kottke; D Ange; L Buddharaju; I Gojo; W E Highsmith; R T Belly; R J Hohl; M E Rybak; A Thibault; J Rosenblatt
Journal: Blood Date: 2001-06-01 Impact factor: 22.113

7. The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency.

Authors: Annalisa Marcuzzi; Luigina De Leo; Giuliana Decorti; Sergio Crovella; Alberto Tommasini; Alessandra Pontillo
Journal: Pediatr Res Date: 2011-07 Impact factor: 3.756